Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Los Angeles Times (LT) - TUESDAY July 9, 1996 Edition: Home Edition Section: Metro Page: 6 Pt. B Story Type: Editorial Word Count: 322
The conference brings physicians, researchers and scientists together to discuss what has been learned about the disease and the precipitating virus, HIV, that now afflicts 25 million people worldwide. Nationally, it is estimated that one in 300 Americans older than 13 has HIV. In recent years, the conferences have been dominated by daunting reports. Now, there is guarded hope of bringing the AIDS pandemic under control, though there remains no cure.
The biggest news: the effectiveness of combining a new generation of HIV-fighting drugs (protease inhibitors) with older reverse transcriptase inhibitors such as 3TC and AZT. Acting in concert, the drugs have at least temporarily reduced HIV viral concentrations to levels that cannot be detected with even the most sensitive techniques. This development allows the body's immune system to rebound to a healthier status, which can promise a longer life to AIDS victims. In one study begun last year of 12 newly HIV-infected men, physicians have found no trace of the virus after nearly a year.
Still, these are short-term findings, and they point mostly to the possibility of treating HIV/AIDS as a chronic but manageable disease. The research, however, involves strains of the virus that are most prevalent in the United States. Questions remain about effectiveness involving strains found elsewhere.
There is still no cure for AIDS, and the search for a vaccine continues. Meanwhile, the new AIDS drugs cost up to $16,000 a year. That level of treatment is inaccessible for many Americans, not to mention AIDS patients in developing nations.
The lessons here include the continued need for early detection and HIV tests on an annual basis for everyone. Most important, people must be taught how to avoid the disease, particularly teenagers, who account for 25% of new HIV infections in the U.S. Learn and live.
960709
LT960705
Copyright © 1996 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .